# Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection

> **NCT07386626** · NA · RECRUITING · sponsor: **Tongji Hospital** · enrollment: 118 (estimated)

## Conditions studied

- Lobectomy

## Interventions

- **DRUG:** Tegileridine
- **PROCEDURE:** Intercostal Nerve Block
- **DRUG:** Sufentanil

## Key facts

- **NCT ID:** NCT07386626
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-03-18
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-01-31
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2026-04-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07386626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07386626, "Tegileridine Combined With Intercostal Nerve Block After Thoracoscopic Lung Resection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07386626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*